This HTML5 document contains 98 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n6http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q83268686
rdf:type
wikibase:Item
schema:description
scientific article published on 31 January 2009 наукова стаття, опублікована в січні 2009 im Januar 2009 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu en xineru de 2009 wetenschappelijk artikel
p:P577
wds:Q83268686-AD4EB36F-60A9-4268-BDB0-66B9F8621C88
wdt:P577
2009-01-31T00:00:00Z
p:P2860
wds:Q83268686-24C27B12-D392-423C-BAE3-1296506AEF89 wds:Q83268686-286BEB77-3074-4FDB-A0FD-6C7279A176EF wds:Q83268686-7DAF3132-B09C-4A82-A024-F100D7282A39 wds:Q83268686-8F84CD77-5C4A-4A40-8684-8949CD31055F wds:Q83268686-965226F0-5EEB-4027-B168-6D5D4F4EE596 wds:Q83268686-B01E6AAB-30FC-4496-AF32-4881C1931258 wds:Q83268686-5CD9E4D0-5718-4354-AA2F-EDD99D95710E wds:Q83268686-66925021-8363-4BF8-AAD6-F7DD50D7D0EB wds:Q83268686-FD4C38F1-A347-44A7-BD9C-EB459FBC120C wds:Q83268686-C2BD0DCD-5DAD-4B42-AA42-03961979BD8E wds:Q83268686-FAEB65B1-E6F9-4C9E-AE2A-C132189EF5E1 wds:Q83268686-351CC177-E2A1-4C58-AE57-042AD3D2C7C3 wds:Q83268686-3DB3DF14-2160-4480-9298-79BDAD8CBA10 wds:Q83268686-4511A1DA-CBBC-4506-BB40-7F9A4A4DD6A3 wds:Q83268686-45ADF12D-3163-4D42-B4EF-774A558FE712 wds:Q83268686-500A0E7E-C604-486A-8EB2-DD68D758EAC4 wds:Q83268686-50415AA8-F28F-4EEB-835B-260EFC2FD3C7 wds:Q83268686-018BC6F0-325F-4FCB-A90A-794303AFBEE8 wds:Q83268686-046C4AF4-7578-4FAB-AA0E-5125C677B956 wds:Q83268686-18283371-80E4-4F94-99B2-1BF957A2046A wds:Q83268686-221532CC-AEFB-4A62-B350-F8B76D8BB5DF
wdt:P2860
wd:Q79776209 wd:Q77795880 wd:Q44023497 wd:Q33429552 wd:Q40673230 wd:Q33348987 wd:Q33959827 wd:Q37305477 wd:Q29615603 wd:Q33364853 wd:Q53298171 wd:Q33959833 wd:Q52925628 wd:Q27860904 wd:Q33364857 wd:Q53263238 wd:Q77357035 wd:Q80656464 wd:Q53939205 wd:Q33332312 wd:Q44680178
p:P2093
wds:Q83268686-FCA39E69-EDC6-43F5-A001-7F653F4B181E wds:Q83268686-F057ED0B-AF8A-4BC6-B108-DA79D3DFC8DC wds:Q83268686-ED91E96C-53E1-436C-B42E-8C679E6BDCC4 wds:Q83268686-EE983FEC-EAAD-4643-8F0B-2B97912F14D8 wds:Q83268686-6BE180DE-6F3C-4613-87A1-FD7A52F0A334 wds:Q83268686-34D287BC-4C56-4BD1-AFD9-C53F4F0C8C9B wds:Q83268686-0055E41C-9CE6-49F2-AD03-F05B399533A1
wdt:P2093
Tsuyoshi Iwasaka Haruhiko Fukuda Toru Nakanishi Ikuo Konishi Taro Shibata Masayuki Hatae Hiroaki Kobayashi
rdfs:label
Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206 Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206
skos:prefLabel
Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206 Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206
schema:name
Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206 Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206
p:P50
wds:Q83268686-0FA8535F-45D6-426E-9021-937DF8CC2A00 wds:Q83268686-721429C4-0300-4E40-80AB-8CAE22502615 wds:Q83268686-595EEF65-2840-44CE-A0F5-2E082E66F8EA
wdt:P50
wd:Q114357818 wd:Q56073489 wd:Q114357862
p:P1476
wds:Q83268686-806B3C50-A50B-4AEF-AF22-9C8CD7ABA4D2
wdt:P1476
Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206
p:P304
wds:Q83268686-D011B30F-14C6-42BF-859F-9F165BEB51A1
wdt:P304
57-62
p:P31
wds:Q83268686-974949F8-C44D-4EA2-9C23-2EDFB15DFEDC
wdt:P31
wd:Q13442814
p:P921
wds:Q83268686-674FF45D-7992-46F9-BA82-957B65188C37 wds:Q83268686-97D84FFA-393D-49E0-ADDE-B4F2796F87C5
wdt:P921
wd:Q108855558 wd:Q12322152
p:P698
wds:Q83268686-3883D37D-22DE-4FB3-B07D-AD93E297957B
wdtn:P698
n10:19181369
wdt:P698
19181369
p:P1433
wds:Q83268686-510E2BFF-1EBA-431C-A151-FE2FDD11F143
wdt:P1433
wd:Q5625182
p:P433
wds:Q83268686-F6C969C1-6F7D-4DA8-A8FB-9C0D54F9BAC6
p:P478
wds:Q83268686-60D7E6C0-A1F6-4FF9-B42E-C9FB927EB467
wdt:P433
1
wdt:P478
113
p:P356
wds:Q83268686-3EA1217E-68F2-48A5-A5B9-6343BCA1E2B2
wdtn:P356
n6:J.YGYNO.2008.12.027
wdt:P356
10.1016/J.YGYNO.2008.12.027